KEYNOTE-B96 Brings Immunotherapy-Based Option to Platinum-Resistant Ovarian Cancer

Journal article

Targeted therapies in oncology

04/15/2026

Abstract

Cancer therapies

FDA approval

Immunotherapy

Ovarian cancer

1 Record Views

Title: KEYNOTE-B96 Brings Immunotherapy-Based Option to Platinum-Resistant Ovarian Cancer
Creators: Bradley Monk
Publication Details: Targeted therapies in oncology
Publisher: MultiMedia Healthcare Inc
Identifiers: 991006263712802656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article